MIMIC
Live / Applied — Suspended — suspension letter mailed (as of 27 Jan 2025)
What this means for you
Not registered yet, but its 16 May 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97938004
- Mark type
- Stylized text
- Filed
- 16 May 2023
- Attorney of record
- Christina M. Licursi
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical, therapeutic and biopharmaceutical preparations and agents for use in the treatment of autoimmune diseases, cancer, cardiovascular diseases and disorders, metabolic diseases and disorders, obesity, endocrine diseases and disorders, gastrointestinal diseases and disorders, hepatic diseases and disorders, nonalcoholic steatohepatitis, non-alcoholic fatty liver disease, ocular diseases and disorders, infectious diseases, psychiatric and psychological diseases and disorders, neurological diseases and disorders, rare diseases, and respiratory diseases and disorders; none of the foregoing for or related to topical pharmaceutical preparations for the treatment of dermatological diseases, disorders and conditions
- Class 009 — Scientific and electric apparatus: Downloadable software featuring artificial intelligence, computational methods, and machine learning models for data analysis in the fields of biomedical, and genomic research; downloadable software featuring artificial intelligence, computational methods, and machine learning models for the design and characterization of biologic therapeutic products and drug analysis in drug discovery and development; downloadable software for the capture, collection, conversion, analysis, communication, processing, receiving, recording, storage and transmission of data, images, information and artificial intelligence in the fields of healthcare, biomedical and genomic research
- Class 042 — Scientific and technological services: Scientific research, namely, research and analysis services in the fields of artificial intelligence and machine learning analytics and scientific and technological research relating to drug development; providing temporary use of online non-downloadable software featuring artificial intelligence, computational methods, and machine learning models for data analysis in the fields of biomedical, and genomic research; providing temporary use of online non-downloadable software featuring artificial intelligence, computational methods, and machine learning models for the design and characterization of biologic therapeutic products and drug analysis in drug discovery and development; providing temporary use of online non-downloadable software for the capture, collection, conversion, analysis, communication, processing, receiving, recording, storage and transmission of data, images, information and artificial intelligence in the fields of healthcare, biomedical and genomic research
Owner
- Metaphore Biotechnologies, Inc., Cambridge, MA, US
Prosecution history
- 10 Feb 2026 — SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
- 10 Aug 2025 — SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
- 27 Jan 2025 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 27 Jan 2025 — LETTER OF SUSPENSION E-MAILED
- 27 Jan 2025 — SUSPENSION LETTER WRITTEN
- 29 Oct 2024 — SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
- 13 Dec 2023 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 13 Dec 2023 — LETTER OF SUSPENSION E-MAILED
- 13 Dec 2023 — SUSPENSION LETTER WRITTEN
- 07 Dec 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 07 Dec 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 07 Dec 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 29 Sept 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 29 Sept 2023 — NON-FINAL ACTION E-MAILED
- 29 Sept 2023 — NON-FINAL ACTION WRITTEN